Penny Daynes, Associate Regional Pharmacy procurement specialist at SPS, presents a summary of the resources published by SPS between 1st and 7th November.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
The licence and supporting evidence for ranibizumab biosimilars
Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-ranibizumab-biosimilar/
Preparing to use ranibizumab biosimilar
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
https://www.sps.nhs.uk/articles/preparing-to-use-ranibizumab-biosimilar/
Restricted to NHS: The licence and supporting evidence for aflibercept biosimilars (log in required)
Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/
New Medicines News
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
https://www.sps.nhs.uk/articles/new-medicines-news/
Medicines Governance Do Once (MGDO) programme opportunity
Contact jo.jenkins2@nhs.net for more information. Closing date for applications 30 November 2025.
Next events
Forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
All content for NHS Specialist Pharmacy Service is the property of NHS Specialist Pharmacy Service and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Penny Daynes, Associate Regional Pharmacy procurement specialist at SPS, presents a summary of the resources published by SPS between 1st and 7th November.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
The licence and supporting evidence for ranibizumab biosimilars
Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-ranibizumab-biosimilar/
Preparing to use ranibizumab biosimilar
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
https://www.sps.nhs.uk/articles/preparing-to-use-ranibizumab-biosimilar/
Restricted to NHS: The licence and supporting evidence for aflibercept biosimilars (log in required)
Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/
New Medicines News
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
https://www.sps.nhs.uk/articles/new-medicines-news/
Medicines Governance Do Once (MGDO) programme opportunity
Contact jo.jenkins2@nhs.net for more information. Closing date for applications 30 November 2025.
Next events
Forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
Rakhi talks to Antonio about newer therapies for lipid management, incliseran and bemepdoic acid. They discuss their place in therapy and how they may be initiated in primary care.
This is final part of our three-part series.
Antonio Ochoa-Ferraro: Consultant Pharmacist, Inherited Metabolic Disorders; University Hospitals of Birmingham
Rakhi Aggarwal: Primary Care Lead, Medicines Use and Safety; NHS SPS
Useful links
Cholesterol and Cholesterol levels
https://www.heartuk.org.uk/cholesterol/overview
NICE guidance
Inclisiran: https://www.nice.org.uk/guidance/TA733
Bempedopic acid with ezetimibe: https://www.nice.org.uk/guidance/ta694
NHS England summary of national guidance for lipid management
https://www.england.nhs.uk/aac/publication/summary-of-national-guidance-for-lipid-management/
NHS Birmingham and Solihull ICB procurement & prescribing of inclisiran
https://www.birminghamandsurroundsformulary.nhs.uk/docs/files/Procurement%20and%20Prescribing%20of%20Inclisiran.pdf?UNLID=93161104220252141045
Novartis inclisiran resources
https://www.pro.novartis.com/uk-en/medicines/cardio-metabolic/leqvio/resources
Open Access Articles
Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran
https://pubmed.ncbi.nlm.nih.gov/38456415/
Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial
https://pubmed.ncbi.nlm.nih.gov/38753448/
Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis
https://pubmed.ncbi.nlm.nih.gov/39921511/
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society
https://pubmed.ncbi.nlm.nih.gov/23956253/
NHS Specialist Pharmacy Service
Penny Daynes, Associate Regional Pharmacy procurement specialist at SPS, presents a summary of the resources published by SPS between 1st and 7th November.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
The licence and supporting evidence for ranibizumab biosimilars
Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-ranibizumab-biosimilar/
Preparing to use ranibizumab biosimilar
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
https://www.sps.nhs.uk/articles/preparing-to-use-ranibizumab-biosimilar/
Restricted to NHS: The licence and supporting evidence for aflibercept biosimilars (log in required)
Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/
New Medicines News
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
https://www.sps.nhs.uk/articles/new-medicines-news/
Medicines Governance Do Once (MGDO) programme opportunity
Contact jo.jenkins2@nhs.net for more information. Closing date for applications 30 November 2025.
Next events
Forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
